GlaxoSmithKline Knew Paxil Likely Caused Birth Defects As Early As 2001
A former GlaxoSmithKline executive testified that the drug maker knew as early as 2001 that the antidepressant Paxil could likely cause birth defects in the fetuses of pregnant women.
In a videotaped deposition, former Glaxo drug-safety executive Jane Nieman said that the company was “almost certain” that Paxil was to blame for a heart defect that caused a patient to abort a fetus in 2001. More than 600 lawsuits allege that Paxil hid the risks of Paxil in order to increase profits.
The family of Lyam Kilker claims Glaxo withheld information from consumers and regulators about the risk of birth defects and failed to properly test Paxil. Lyam’s mother, Michelle David, blames Paxil for causing her son’s life-threatening heart defects.
The attorneys of Bahe Cook Cantley & Jones PLC represent people injured by unreasonably dangerous drugs and products in Kentucky and Indiana.
